Cardiac arrest & resuscitation
Paucity of neuroprognostic testing after cardiac arrest in the United States
Authors' conclusion
In this retrospective cohort, we found few patients hospitalized after out-of-hospital cardiac arrest underwent guideline-recommended prognostic testing.
Study context
- Population
- In-hospital decedents admitted after resuscitation from non-traumatic cardiac arrest, Optum EHR dataset, 2010–2021
- Participants
- 34,585 decedents
- Outcome
- Frequency and timing of guideline-recommended neuroprognostic testing (head CT, EEG, SSEP, brain MRI, neurologist evaluation) before in-hospital death
Main finding
As reported in the abstract
≥1 neurodiagnostic test
3,245
9%
Evaluated by a neurologist
1,708
5%
Head CT (most common test)
3,004
9%
≥2 diagnostic modalities
852
2%
Observational data: associations, not effects.
Further findings
Hospital length of stay and timing of death
- Median hospital length of stay (IQR 0-1), days
- 0
- Deaths on or after day 3
- 16%
Original publication
Paucity of neuroprognostic testing after cardiac arrest in the United States. Resuscitation. Published 15 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →